{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:15:59Z","timestamp":1788948959105,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-04169-3","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T07:02:56Z","timestamp":1767682976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of a prognostic model for thyroid cancer based on mitochondrial metabolism-related genes and immune profiling"],"prefix":"10.1186","volume":"24","author":[{"given":"Guorui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinchao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"4169_CR1","doi-asserted-by":"crossref","unstructured":"Dabravolski SA, Nikiforov NG, Zhuravlev AD, Orekhov NA, Mikhaleva LM. A.N. Orekhov the role of altered mitochondrial metabolism in thyroid cancer development and Mitochondria-Targeted thyroid cancer treatment. Int J Mol Sci. 2021;23(1):460.","DOI":"10.3390\/ijms23010460"},{"issue":"1","key":"4169_CR2","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.1038\/s41467-024-50192-5","volume":"15","author":"R Mart\u00ednez-Hern\u00e1ndez","year":"2024","unstructured":"Mart\u00ednez-Hern\u00e1ndez R, S\u00e1nchez N, de la Blanca P, Sacrist\u00e1n-G\u00f3mez A, Serrano-Somavilla JL, De Mu\u00f1oz F, S\u00e1nchez, Cabo, et al. Unraveling the molecular architecture of autoimmune thyroid diseases at Spatial resolution. Nat Commun. 2024;15(1):5895.","journal-title":"Nat Commun"},{"key":"4169_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fendo.2020.00082","volume":"11","author":"D Laha","year":"2020","unstructured":"Laha D, Nilubol N. Boufraqech new therapies for advanced thyroid cancer. Front Endocrinol. 2020;11:82.","journal-title":"Front Endocrinol"},{"issue":"4","key":"4169_CR4","first-page":"225","volume":"9","author":"A Miranda-Filho","year":"2021","unstructured":"Miranda-Filho A, Lortet-Tieulent J, Bray F, Cao B, Franceschi S, Vaccarella S, et al. Thyroid cancer incidence trends by histology in 25 countries: a population-based study, the lancet. Diabetes Endocrinol. 2021;9(4):225\u201334.","journal-title":"Diabetes Endocrinol"},{"issue":"2","key":"4169_CR5","doi-asserted-by":"publisher","first-page":"100825","DOI":"10.1016\/j.tvir.2022.100825","volume":"25","author":"P Pace-Asciak","year":"2022","unstructured":"Pace-Asciak P, Russell JO. Tufano the treatment of thyroid cancer with radiofrequency ablation. Tech Vasc Interv Radiol. 2022;25(2):100825.","journal-title":"Tech Vasc Interv Radiol"},{"key":"4169_CR6","doi-asserted-by":"crossref","unstructured":"RP Tufano, P Pace-Asciak, JO Russell, C Su\u00e1rez, GW Randolph, F L\u00f3pez, et al. Update of radiofrequency ablation for treating benign and malignant thyroid Nodules. The future is now. Front Endocrinol. 2021;12:698689.","DOI":"10.3389\/fendo.2021.698689"},{"key":"4169_CR7","doi-asserted-by":"crossref","unstructured":"Ancker OV, Kr\u00fcger M, Wehland M, Infanger M. D. Grimm multikinase inhibitor treatment in thyroid cancer. Int J Mol Sci. 2019;21(1):10.","DOI":"10.3390\/ijms21010010"},{"key":"4169_CR8","doi-asserted-by":"publisher","first-page":"216304","DOI":"10.1016\/j.canlet.2023.216304","volume":"568","author":"AJ Sugarman","year":"2023","unstructured":"Sugarman AJ, Huynh LD, Di Shabro A. Cristofano anaplastic thyroid cancer cells upregulate mitochondrial one-carbon metabolism to Meet purine demand, eliciting a critical targetable vulnerability. Cancer Lett. 2023;568:216304.","journal-title":"Cancer Lett"},{"issue":"20","key":"4169_CR9","doi-asserted-by":"publisher","first-page":"e113743","DOI":"10.15252\/embj.2023113743","volume":"42","author":"W Jiang","year":"2023","unstructured":"Jiang W, Zhang M, Gao C, Yan C, Gao R, He Z, et al. A mitochondrial EglN1-AMPK\u03b1 axis drives breast cancer progression by enhancing metabolic adaptation to hypoxic stress. EMBO J. 2023;42(20):e113743.","journal-title":"EMBO J"},{"issue":"14","key":"4169_CR10","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.2174\/1871520622666220215123620","volume":"22","author":"Y Li","year":"2022","unstructured":"Li Y, Sun Q, Chen S, Yu X, Jing H. Monensin inhibits anaplastic thyroid cancer via disrupting mitochondrial respiration and AMPK\/mTOR signaling. Anti-cancer Agents Med Chem. 2022;22(14):2539\u201347.","journal-title":"Anti-cancer Agents Med Chem"},{"issue":"44","key":"4169_CR11","doi-asserted-by":"publisher","first-page":"4893","DOI":"10.1038\/s41388-022-02484-7","volume":"41","author":"WKL Doolittle","year":"2022","unstructured":"Doolittle WKL, Park S, Lee SG, Jeong S, Lee G, Ryu D, et al. Non-genomic activation of the AKT-mTOR pathway by the mitochondrial stress response in thyroid cancer. Oncogene. 2022;41(44):4893\u2013904.","journal-title":"Oncogene"},{"issue":"1","key":"4169_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12957-022-02799-5","volume":"20","author":"J Xing","year":"2022","unstructured":"Xing J, Qi L, Liu X, Shi G, Sun X. Yang roles of mitochondrial fusion and fission in breast cancer progression: a systematic review. World J Surg Oncol. 2022;20(1):331.","journal-title":"World J Surg Oncol"},{"issue":"3","key":"4169_CR13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cmet.2020.06.019","volume":"32","author":"K Vasan","year":"2020","unstructured":"Vasan K, Werner M. Chandel mitochondrial metabolism as a target for cancer therapy. Cell Metabol. 2020;32(3):341\u201352.","journal-title":"Cell Metabol"},{"key":"4169_CR14","doi-asserted-by":"crossref","unstructured":"Frattaruolo L, Brindisi M, Curcio R, Marra F, Dolce V. A.R. Cappello targeting the mitochondrial metabolic network: A promising strategy in cancer treatment. Int J Mol Sci. 2020;21(17):6014.","DOI":"10.3390\/ijms21176014"},{"key":"4169_CR15","doi-asserted-by":"crossref","unstructured":"Caban\u00e9 P, Correa C, Bode I, Aguilar R. A.A. Elorza biomarkers in thyroid cancer: emerging opportunities from Non-Coding RNAs and mitochondrial space. Int J Mol Sci. 25(12):6719.","DOI":"10.3390\/ijms25126719"},{"issue":"1","key":"4169_CR16","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1038\/s41467-024-46377-7","volume":"15","author":"L Simula","year":"2024","unstructured":"Simula L, Fumagalli M, Vimeux L, Rajnpreht I, Icard P, Birsen G, et al. Mitochondrial metabolism sustains CD8(+) T cell migration for an efficient infiltration into solid tumors. Nat Commun. 2024;15(1):2203.","journal-title":"Nat Commun"},{"key":"4169_CR17","doi-asserted-by":"crossref","unstructured":"Zhang P, Zhang M, Liu J, Zhou Z, Zhang L, Luo P et al. Mitochondrial pathway signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma. J Immunother Cancer. 2025;13(7):e012069.","DOI":"10.1136\/jitc-2025-012069"},{"issue":"2","key":"4169_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10863-020-09824-w","volume":"52","author":"L Ma","year":"2020","unstructured":"Ma L. Fei antimalarial drug Artesunate is effective against chemoresistant anaplastic thyroid carcinoma via targeting mitochondrial metabolism. J Bioenerg Biomembr. 2020;52(2):123\u201330.","journal-title":"J Bioenerg Biomembr"},{"issue":"1","key":"4169_CR19","doi-asserted-by":"publisher","first-page":"11747","DOI":"10.1038\/s41598-018-29938-x","volume":"8","author":"Y Xiong","year":"2018","unstructured":"Xiong Y, Liu W, Huang Q, Wang J, Wang Y, Li H, et al. Tigecycline as a dual inhibitor of retinoblastoma and angiogenesis via inducing mitochondrial dysfunctions and oxidative damage. Sci Rep. 2018;8(1):11747.","journal-title":"Sci Rep"},{"issue":"4","key":"4169_CR20","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41568-024-00670-1","volume":"24","author":"V Mohanty","year":"2024","unstructured":"Mohanty V. Inferring cancer metabolism from gene-expression data. Nat Rev Cancer. 2024;24(4):230.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"4169_CR21","first-page":"425","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai L, Zafereo M. M E Cabanillas Thyroid Cancer: Rev Jama. 2024;331(5):425\u201335.","journal-title":"M E Cabanillas Thyroid Cancer: Rev Jama"},{"issue":"6","key":"4169_CR22","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1080\/15548627.2024.2312790","volume":"20","author":"S D\u00edaz-Gago","year":"2024","unstructured":"D\u00edaz-Gago S, Vicente-Guti\u00e9rrez J, Ruiz-Rodr\u00edguez JM, Calafell J, \u00c1lvarez-\u00c1lvarez A, Lasa M, et al. Autophagy sustains mitochondrial respiration and determines resistance to BRAF(V600E) Inhibition in thyroid carcinoma cells. Autophagy. 2024;20(6):1383\u201397.","journal-title":"Autophagy"},{"issue":"7","key":"4169_CR23","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/s41418-022-01022-y","volume":"29","author":"L Sainero-Alcolado","year":"2022","unstructured":"Sainero-Alcolado L, Lia\u00f1o-Pons J, Ruiz-P\u00e9rez MV. Arsenian-Henriksson targeting mitochondrial metabolism for precision medicine in cancer. Cell Death Differ. 2022;29(7):1304\u201317.","journal-title":"Cell Death Differ"},{"issue":"31","key":"4169_CR24","doi-asserted-by":"publisher","first-page":"e29972","DOI":"10.1097\/MD.0000000000029972","volume":"101","author":"ZX Yu","year":"2022","unstructured":"Yu ZX, Xiang C, Xu SG. Zhang the clinical significance of thyroid hormone-responsive in thyroid carcinoma and its potential regulatory pathway. Medicine. 2022;101(31):e29972.","journal-title":"Medicine"},{"issue":"1","key":"4169_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.mce.2009.01.005","volume":"302","author":"GW Anderson","year":"2009","unstructured":"Anderson GW, Zhu Q, Metkowski J, Stack MJ, Gopinath S. Mariash the Thrsp null mouse (Thrsp(tm1cnm)) and diet-induced obesity. Mol Cell Endocrinol. 2009;302(1):99\u2013107.","journal-title":"Mol Cell Endocrinol"},{"key":"4169_CR26","doi-asserted-by":"crossref","unstructured":"Vella V. R. Malaguarnera the emerging role of insulin receptor isoforms in thyroid cancer: clinical implications and new perspectives. Int J Mol Sci. 2018;19(12):3814.","DOI":"10.3390\/ijms19123814"},{"issue":"4","key":"4169_CR27","doi-asserted-by":"publisher","first-page":"723","DOI":"10.21037\/tp-20-301","volume":"10","author":"Y Yu","year":"2021","unstructured":"Yu Y, Wang S, Zhang X, Xu S, Li Y, Liu Q, et al. Clinical implications of TPO and AOX1 in pediatric papillary thyroid carcinoma. Translational Pediatr. 2021;10(4):723\u201332.","journal-title":"Translational Pediatr"},{"issue":"11","key":"4169_CR28","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1055\/s-2007-992129","volume":"39","author":"A Sigruener","year":"2007","unstructured":"Sigruener A, Buechler C, Ors\u00f3 E, Hartmann A, Wild P.J., Terracciano L, et al. Human aldehyde oxidase 1 interacts with ATP-binding cassette transporter-1 and modulates its activity in hepatocytes. Hormone Metabolic Res = Hormon- Und Stoffwechselforschung = Horm Et Metab. 2007;39(11):781\u20139.","journal-title":"Hormone Metabolic Res = Hormon- Und Stoffwechselforschung = Horm Et Metab"},{"key":"4169_CR29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.cbi.2019.04.030","volume":"307","author":"J Gim\u00e9nez-Dejoz","year":"2019","unstructured":"Gim\u00e9nez-Dejoz J, Weber S, Fern\u00e1ndez-Pardo \u00c1, M\u00f6ller G, Adamski J, Port\u00e9 S, et al. Engineering aldo-keto reductase 1B10 to mimic the distinct 1B15 topology and specificity towards inhibitors and substrates, including retinoids and steroids. Chemico-Biol Interact. 2019;307:186\u201394.","journal-title":"Chemico-Biol Interact"},{"issue":"10","key":"4169_CR30","doi-asserted-by":"publisher","first-page":"6531","DOI":"10.1074\/jbc.M114.610121","volume":"290","author":"S Weber","year":"2015","unstructured":"Weber S, Salabei JK, M\u00f6ller G, Kremmer E, Bhatnagar A, Adamski J, et al. Aldo-keto reductase 1B15 (AKR1B15): a mitochondrial human aldo-keto reductase with activity toward steroids and 3-keto-acyl-CoA conjugates. J Biol Chem. 2015;290(10):6531\u201345.","journal-title":"J Biol Chem"},{"issue":"1","key":"4169_CR31","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41420-024-02240-8","volume":"10","author":"N Liu","year":"2024","unstructured":"Liu N, Zhu XR, Wu CY, Liu YY, Chen MB. Gu PCK1 as a target for cancer therapy: from metabolic reprogramming to immune microenvironment remodeling. Cell Death Discovery. 2024;10(1):478.","journal-title":"Cell Death Discovery"},{"issue":"50","key":"4169_CR32","doi-asserted-by":"publisher","first-page":"6707","DOI":"10.1038\/s41388-021-02058-z","volume":"40","author":"R Liu","year":"2021","unstructured":"Liu R, Gou D, Xiang J, Pan X, Gao Q, Zhou P, et al. O-GlcNAc modified-TIP60\/KAT5 is required for PCK1 deficiency-induced HCC metastasis. Oncogene. 2021;40(50):6707\u201319.","journal-title":"Oncogene"},{"key":"4169_CR33","first-page":"83","volume":"1513","author":"TF Day","year":"2017","unstructured":"Day TF, Mewani RR, Starr J, Li X, Chakravarty D, Ressom H, et al. Transcriptome and proteome analyses of TNFAIP8 knockdown cancer cells reveal new insights into molecular determinants of cell survival and tumor progression. (Clifton N J). 2017;1513:83\u2013100. Methods in molecular biology.","journal-title":"(Clifton N J)"},{"key":"4169_CR34","doi-asserted-by":"publisher","first-page":"1566363","DOI":"10.3389\/fmolb.2025.1566363","volume":"12","author":"C Yue","year":"2025","unstructured":"Yue C, Zheng X, Ye Y, Li D, Zhou Y. TNFAIP8L3 regulation of the TGF-\u03b2 signaling pathway affects the proportion of macrophages during tumor antigen presentation and affects the prognosis of ovarian cancer. Front Mol Biosci. 2025;12:1566363.","journal-title":"Front Mol Biosci"},{"issue":"4","key":"4169_CR35","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41419-023-05775-3","volume":"14","author":"W Chen","year":"2023","unstructured":"Chen W, Chen X, Wang L, Yang R, Zhang W, Zhang S, et al. TIPE3 represses head and neck squamous cell carcinoma progression via triggering PGAM5 mediated mitochondria dysfunction. Cell Death Dis. 2023;14(4):251.","journal-title":"Cell Death Dis"},{"issue":"4","key":"4169_CR36","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41419-022-04818-5","volume":"13","author":"H Song","year":"2022","unstructured":"Song H, Tian D, Sun J, Mao X, Kong W, Xu D, et al. circFAM120B functions as a tumor suppressor in esophageal squamous cell carcinoma via the miR-661\/PPM1L axis and the PKR\/p38 MAPK\/EMT pathway. Cell Death Dis. 2022;13(4):361.","journal-title":"Cell Death Dis"},{"issue":"2","key":"4169_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/gcc.20724","volume":"49","author":"LF Thean","year":"2010","unstructured":"Thean LF, Loi C, Ho KS, Koh PK, Eu KW. Cheah Genome-wide scan identifies a copy number variable region at 3q26 that regulates PPM1L in APC mutation-negative Familial colorectal cancer patients. Genes Chromosomes Cancer. 2010;49(2):99\u2013106.","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"4169_CR38","doi-asserted-by":"publisher","first-page":"16496","DOI":"10.1038\/s41598-023-43289-2","volume":"13","author":"H Ding","year":"2023","unstructured":"Ding H, Wang KY, Chen SY, Guo KW. Qiu validating the role of PTGIS gene in colorectal cancer by bioinformatics analysis and in vitro experiments. Sci Rep. 2023;13(1):16496.","journal-title":"Sci Rep"},{"key":"4169_CR39","doi-asserted-by":"publisher","first-page":"115659","DOI":"10.1016\/j.biopha.2023.115659","volume":"168","author":"J Ouyang","year":"2023","unstructured":"Ouyang J, Feng Y, Zhang Y, Liu Y, Li S, Wang J, et al. Integration of metabolomics and transcriptomics reveals Metformin suppresses thyroid cancer progression via inhibiting Glycolysis and restraining DNA replication. Biomed pharmacotherapy = Biomedecine Pharmacotherapie. 2023;168:115659.","journal-title":"Biomed pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"4169_CR40","doi-asserted-by":"publisher","first-page":"e923673","DOI":"10.12659\/MSM.923673","volume":"26","author":"L Cheng","year":"2020","unstructured":"Cheng L, Tan Z, Huang Z, Pan Y, Zhang W. Wang expression profile and prognostic values of Mini-Chromosome maintenance families (MCMs) in breast cancer. Med Sci Monitor: Int Med J Experimental Clin Res. 2020;26:e923673.","journal-title":"Med Sci Monitor: Int Med J Experimental Clin Res"},{"key":"4169_CR41","doi-asserted-by":"publisher","first-page":"114488","DOI":"10.1016\/j.biopha.2023.114488","volume":"161","author":"X Cui","year":"2023","unstructured":"Cui X, Liu R, Duan L, Zhang Q, Cao D. Zhang exogenous hydrogen sulfide (H(2)S) exerts therapeutic potential in triple-negative breast cancer by affecting cell cycle and DNA replication pathway. Biomed pharmacotherapy = Biomedecine Pharmacotherapie. 2023;161:114488.","journal-title":"Biomed pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"4169_CR42","doi-asserted-by":"crossref","unstructured":"Han PZ, Ye WD, Yu PC, Tan LC, Shi X, Chen XF et al. A distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but immunotherapy sensitive than papillary thyroid cancer. JCI Insight. 2024;9(8):e173712.","DOI":"10.1172\/jci.insight.173712"},{"issue":"6","key":"4169_CR43","doi-asserted-by":"publisher","first-page":"112599","DOI":"10.1016\/j.celrep.2023.112599","volume":"42","author":"RA Ramirez-Valdez","year":"2023","unstructured":"Ramirez-Valdez RA, Baharom F, Khalilnezhad A, Fussell SC, Hermans DJ, Schrager AM, et al. Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression. Cell Rep. 2023;42(6):112599.","journal-title":"Cell Rep"},{"issue":"3","key":"4169_CR44","doi-asserted-by":"publisher","first-page":"36","DOI":"10.21037\/cco-23-133","volume":"13","author":"A Pinheiro Neto","year":"2024","unstructured":"Pinheiro Neto A, Lucchesi HL, Valsecchi V, Ward LS. L.L. Cunha immunotherapy for patients with thyroid cancer: a comprehensive appraisal. Chin Clin Oncol. 2024;13(3):36.","journal-title":"Chin Clin Oncol"},{"issue":"1","key":"4169_CR45","doi-asserted-by":"publisher","first-page":"2403170","DOI":"10.1080\/21645515.2024.2403170","volume":"20","author":"Q Wang","year":"2024","unstructured":"Wang Q, Pan G, Zhang Y, Ni Y, Mu Y. Luo emerging insights into thyroid cancer from immunotherapy perspective: A bibliometric analysis. Hum Vaccines Immunotherapeutics. 2024;20(1):2403170.","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"11","key":"4169_CR46","doi-asserted-by":"publisher","first-page":"5464","DOI":"10.7150\/thno.54822","volume":"11","author":"FH Kong","year":"2021","unstructured":"Kong FH, Ye QF, Miao XY, Liu X, Huang SQ, Xiong L, et al. Current status of Sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma. Theranostics. 2021;11(11):5464\u201390.","journal-title":"Theranostics"},{"issue":"10408","key":"4169_CR47","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/S0140-6736(23)00961-3","volume":"402","author":"S Qin","year":"2023","unstructured":"Qin S, Chan SL, Gu S, Bai Y, Ren Z, Lin X, et al. Camrelizumab plus Rivoceranib versus Sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study. Lancet (London England). 2023;402(10408):1133\u201346.","journal-title":"Lancet (London England)"},{"key":"4169_CR48","doi-asserted-by":"publisher","first-page":"175913","DOI":"10.1016\/j.ejphar.2023.175913","volume":"955","author":"Q Li","year":"2023","unstructured":"Li Q, Chen K, Zhang T, Jiang D, Chen L, Jiang J, et al. Understanding sorafenib-induced ferroptosis and resistance mechanisms: implications for cancer therapy. Eur J Pharmacol. 2023;955:175913.","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"4169_CR49","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1056\/NEJMoa2303815","volume":"389","author":"E Bouffet","year":"2023","unstructured":"Bouffet E, Hansford JR, Garr\u00e8 ML, Hara J, Plant-Fox A, Aerts I, et al. Dabrafenib plus Trametinib in pediatric glioma with BRAF V600 mutations. N Engl J Med. 2023;389(12):1108\u201320.","journal-title":"N Engl J Med"},{"issue":"1","key":"4169_CR50","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1200\/JCO.22.00657","volume":"41","author":"M Bharadwaj","year":"2023","unstructured":"Bharadwaj M, Nagda D. Goyal mudras in medicine: A role for dance in appreciating nonverbal communication in the clinical encounter. J Clin Oncology: Official J Am Soc Clin Oncol. 2023;41(1):128\u201331.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"3","key":"4169_CR51","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1200\/JCO.22.01000","volume":"41","author":"E Bouffet","year":"2023","unstructured":"Bouffet E, Geoerger B, Moertel C, Whitlock JA, Aerts I, Hargrave D, et al. Efficacy and safety of Trametinib monotherapy or in combination with Dabrafenib in pediatric BRAF V600-Mutant Low-Grade glioma. J Clin Oncology: Official J Am Soc Clin Oncol. 2023;41(3):664\u201374.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"40","key":"4169_CR52","first-page":"74","volume":"1","author":"Y Alqattan","year":"2022","unstructured":"Alqattan Y, Ali S, Almohammad R, Kayali N. Alhuraiji Dasatinib-induced chylothorax in chronic myeloid leukemia. Gulf J Oncol. 2022;1(40):74\u20137.","journal-title":"Gulf J Oncol"},{"issue":"8","key":"4169_CR53","first-page":"700","volume":"111","author":"RG Crounse","year":"1987","unstructured":"Crounse RG. The diagnostic value of microscopic examination of human hair. Arch Pathol Lab Med. 1987;111(8):700\u20132.","journal-title":"Arch Pathol Lab Med"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04169-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04169-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04169-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T15:03:52Z","timestamp":1770131032000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-025-04169-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4169"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04169-3","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}